Answers are grounded in this paper and cite their sources.
Comparative case report evaluates imaging differences in parotid Warthin tumors, suggesting FAP-targeted PET/CT could differentiate benign from malignant lesions.
Warthin tumor is the second most common benign parotid neoplasm and often shows marked uptake on 18F-FDG PET/CT, frequently mimicking malignancy. In contrast, its imaging characteristics on fibroblast activation protein (FAP)-targeted PET/CT remain insufficiently defined. We report 2 cases of parotid Warthin tumors that demonstrated marked FDG uptake but absent or minimal uptake on FAP-targeted PET/CT using 68Ga-FAPI-04 and 68Ga-FAP-2286. This discordant imaging pattern suggests that FAP-targeted PET/CT may aid in distinguishing Warthin tumor from malignant lesions.
No takes yet. Share an insight, caveat, or question.
Cheng et al. (2026) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: